Cancer Patient Education

Cancer Drugs

blinatumomab

U. Darda Bayraktar, MD

Cancer Drugs

bleomycin

U. Darda Bayraktar, MD

Cancer Drugs

binimetinib

U. Darda Bayraktar, MD

Cancer Drugs

bicalutamide

U. Darda Bayraktar, MD

Cancer Drugs

bevacizumab

U. Darda Bayraktar, MD

19 Dec

Brigatinib

Brigatinib (Alunbrig) is a targeted therapy for ALK‑positive metastatic non-small cell lung cancer. Key risks include lung problems, high blood pressure, slow heartbeat, liver an

19 Dec

brentuximab vedotin

Brentuximab vedotin (Adcetris) is a targeted therapy for certain CD30‑positive lymphomas. You get it by IV infusion. Key risks include PML, serious infections, infusion reactions

19 Dec

bosutinib

Bosutinib is a targeted pill for certain adults with Philadelphia chromosome–positive chronic myeloid leukemia (CML). It blocks BCR-ABL1 and related kinases to slow leukemia cell

bortezomib

Bortezomib (Velcade and other brands) is a proteasome inhibitor used for multiple myeloma and mantle cell lymphoma. It can cause low blood counts, infections, nerve problems, and o

blinatumomab

Blinatumomab (Blincyto) is an immune therapy for certain CD19‑positive acute lymphoblastic leukemias. It can cause serious reactions, including cytokine release syndrome and nerv

bleomycin

Bleomycin is a chemotherapy drug used for certain cancers and to help prevent fluid around the lungs. Serious lung problems can occur, sometimes at low doses. People with lymphoma

binimetinib

Binimetinib is a targeted cancer drug, usually taken with encorafenib, for certain melanoma and lung cancers with BRAF mutations. Learn key warnings, how it works, and common side

bicalutamide

Bicalutamide is an antiandrogen used for prostate cancer. It blocks male hormones from fueling tumor growth. Key risks include rare liver or lung problems, bleeding with warfarin,